These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 20697377

  • 41. Pigment Epithelium-Derived Factor (PEDF) Prevents Hepatic Fat Storage, Inflammation, and Fibrosis in Dietary Steatohepatitis of Mice.
    Yoshida T, Akiba J, Matsui T, Nakamura K, Hisamoto T, Abe M, Ikezono Y, Wada F, Iwamoto H, Nakamura T, Koga H, Yamagishi SI, Torimura T.
    Dig Dis Sci; 2017 Jun; 62(6):1527-1536. PubMed ID: 28365916
    [Abstract] [Full Text] [Related]

  • 42. Enhanced expression of Nrf2 in mice attenuates the fatty liver produced by a methionine- and choline-deficient diet.
    Zhang YK, Yeager RL, Tanaka Y, Klaassen CD.
    Toxicol Appl Pharmacol; 2010 Jun 15; 245(3):326-34. PubMed ID: 20350562
    [Abstract] [Full Text] [Related]

  • 43. S100A4 Gene is Crucial for Methionine-Choline-Deficient Diet-Induced Non-Alcoholic Fatty Liver Disease in Mice.
    Zhang YH, Ma Q, Ding P, Li J, Chen LL, Ao KJ, Tian YY.
    Yonsei Med J; 2018 Nov 15; 59(9):1064-1071. PubMed ID: 30328321
    [Abstract] [Full Text] [Related]

  • 44. Low-Dose Administration of Cannabigerol Attenuates Inflammation and Fibrosis Associated with Methionine/Choline Deficient Diet-Induced NASH Model via Modulation of Cannabinoid Receptor.
    Aljobaily N, Krutsinger K, Viereckl MJ, Joly R, Menlove B, Cone B, Suppes A, Han Y.
    Nutrients; 2022 Dec 30; 15(1):. PubMed ID: 36615835
    [Abstract] [Full Text] [Related]

  • 45. Farnesoid X receptor agonist WAY-362450 attenuates liver inflammation and fibrosis in murine model of non-alcoholic steatohepatitis.
    Zhang S, Wang J, Liu Q, Harnish DC.
    J Hepatol; 2009 Aug 30; 51(2):380-8. PubMed ID: 19501927
    [Abstract] [Full Text] [Related]

  • 46. Deficiency in myeloid differentiation factor-2 and toll-like receptor 4 expression attenuates nonalcoholic steatohepatitis and fibrosis in mice.
    Csak T, Velayudham A, Hritz I, Petrasek J, Levin I, Lippai D, Catalano D, Mandrekar P, Dolganiuc A, Kurt-Jones E, Szabo G.
    Am J Physiol Gastrointest Liver Physiol; 2011 Mar 30; 300(3):G433-41. PubMed ID: 21233280
    [Abstract] [Full Text] [Related]

  • 47. Fibroblast growth factor 21 limits lipotoxicity by promoting hepatic fatty acid activation in mice on methionine and choline-deficient diets.
    Fisher FM, Chui PC, Nasser IA, Popov Y, Cunniff JC, Lundasen T, Kharitonenkov A, Schuppan D, Flier JS, Maratos-Flier E.
    Gastroenterology; 2014 Nov 30; 147(5):1073-83.e6. PubMed ID: 25083607
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Activation of peroxisome proliferator-activated receptor alpha by dietary fish oil attenuates steatosis, but does not prevent experimental steatohepatitis because of hepatic lipoperoxide accumulation.
    Larter CZ, Yeh MM, Cheng J, Williams J, Brown S, dela Pena A, Bell-Anderson KS, Farrell GC.
    J Gastroenterol Hepatol; 2008 Feb 30; 23(2):267-75. PubMed ID: 17868330
    [Abstract] [Full Text] [Related]

  • 52. Dynamic alterations in the gut microbiota and metabolome during the development of methionine-choline-deficient diet-induced nonalcoholic steatohepatitis.
    Ye JZ, Li YT, Wu WR, Shi D, Fang DQ, Yang LY, Bian XY, Wu JJ, Wang Q, Jiang XW, Peng CG, Ye WC, Xia PC, Li LJ.
    World J Gastroenterol; 2018 Jun 21; 24(23):2468-2481. PubMed ID: 29930468
    [Abstract] [Full Text] [Related]

  • 53. Effects of treatment with hydrogen sulfide on methionine-choline deficient diet-induced non-alcoholic steatohepatitis in rats.
    Luo ZL, Tang LJ, Wang T, Dai RW, Ren JD, Cheng L, Xiang K, Tian FZ.
    J Gastroenterol Hepatol; 2014 Jan 21; 29(1):215-22. PubMed ID: 24117897
    [Abstract] [Full Text] [Related]

  • 54. The pathogenesis of ethanol versus methionine and choline deficient diet-induced liver injury.
    Gyamfi MA, Damjanov I, French S, Wan YJ.
    Biochem Pharmacol; 2008 Feb 15; 75(4):981-95. PubMed ID: 18036573
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Adenovirus‑mediated overexpression of bone morphogenetic protein‑9 promotes methionine choline deficiency‑induced non‑alcoholic steatohepatitis in non‑obese mice.
    Li Q, Liu B, Breitkopf-Heinlein K, Weng H, Jiang Q, Dong P, Dooley S, Xu K, Ding H.
    Mol Med Rep; 2019 Sep 15; 20(3):2743-2753. PubMed ID: 31322255
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Rodent nutritional model of non-alcoholic steatohepatitis: species, strain and sex difference studies.
    Kirsch R, Clarkson V, Shephard EG, Marais DA, Jaffer MA, Woodburne VE, Kirsch RE, Hall Pde L.
    J Gastroenterol Hepatol; 2003 Nov 15; 18(11):1272-82. PubMed ID: 14535984
    [Abstract] [Full Text] [Related]

  • 60. Role of adipose triglyceride lipase (PNPLA2) in protection from hepatic inflammation in mouse models of steatohepatitis and endotoxemia.
    Jha P, Claudel T, Baghdasaryan A, Mueller M, Halilbasic E, Das SK, Lass A, Zimmermann R, Zechner R, Hoefler G, Trauner M.
    Hepatology; 2014 Mar 15; 59(3):858-69. PubMed ID: 24002947
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.